BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 5288229)

  • 1. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
    Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
    [No Abstract]   [Full Text] [Related]  

  • 2. Fertility control with Ovral. A clinical review.
    Laurie RE; Lewis ET
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:95-107. PubMed ID: 4256548
    [No Abstract]   [Full Text] [Related]  

  • 3. A low-dosage contraceptive in Public Health clinics.
    Andelman MB; Zackler J; Walters JE
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:117-24. PubMed ID: 5288230
    [No Abstract]   [Full Text] [Related]  

  • 4. Three and one-half years' experience with a lower-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1976 Jun; 16(6):338-44. PubMed ID: 957360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo.
    Cullberg J
    Acta Psychiatr Scand Suppl; 1972; 236():1-86. PubMed ID: 4565340
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-oestrogen combined oral contraceptive.
    Foss GL; Fotherby K
    Acta Eur Fertil; 1973 Jun; 4(2):57-8. PubMed ID: 4784140
    [No Abstract]   [Full Text] [Related]  

  • 7. Fertility control with norgestrel and ethynil estradiol. Report on continuing studies.
    Rice-Wray E; Cervantes A; Garcilazo J; Valenzuela P
    J Reprod Med; 1972 Aug; 9(2):45-9. PubMed ID: 5050402
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of norgestrel in combination with ethinyl oestradiol on the human pituitary-adrenal axis.
    Givens JR; Fort AT; Leigh JH
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:69-76. PubMed ID: 4330931
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of two biphasic and one triphasic norgestrel/ethinyl estradiol regimens.
    Larrañaga A; Sartoretto JN; Winterhalter M; Navas Filho F
    Int J Fertil; 1978; 23(3):193-9. PubMed ID: 40893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of two oral contraceptives containing 50 mu g. and 30 mu g. ethinyl estradiol.
    Dionne P; Vickerson F
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):281-8. PubMed ID: 4208342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review.
    Korba VD; Heil CG
    Fertil Steril; 1975 Oct; 26(10):973-81. PubMed ID: 1183625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of Ovidon, Rigevidon and Postinor for contraception].
    Kulakov VI; Barinov AM; Prilepskaia VN
    Akush Ginekol (Mosk); 1983 Nov; (11):22-4. PubMed ID: 6666791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)].
    Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T
    Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
    Gaudefroy M; Corette L; Coliche D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231
    [No Abstract]   [Full Text] [Related]  

  • 15. Fertility regulation using "triphasic" administration of ethinyl estradiol and levonorgestrel in comparison with the 30 plus 150 micrograms fixed dose regime.
    Zador G
    Acta Obstet Gynecol Scand Suppl; 1979; 88():43-8. PubMed ID: 393049
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with ethinyl estradiol and d-norgestrel as an oral contraceptive.
    Apelo R; Veloso I
    Fertil Steril; 1975 Mar; 26(3):283-8. PubMed ID: 1116622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of a low dose combined oral contraceptive ('Ovranette').
    Foss GL; Fotherby K
    Curr Med Res Opin; 1975; 3(2):72-6. PubMed ID: 1095309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki P
    Ann Clin Res; 1978 Aug; 10(4):242-5. PubMed ID: 707973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years of fertility control with microdose norgestrel: An updated clinical review.
    Korba VD; Paulson SR
    J Reprod Med; 1974 Aug; 13(2):71-5. PubMed ID: 4844517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.